Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 91 AL 105

The emerging risk of exposure to air pollution on cognitive decline and Alzheimer's disease - Evidence from epidemiological and animal studies

Kilian J, Kitazawa M.

Biomed J. 2018 Jun;41(3):141-162. doi: 10.1016/j.bj.2018.06.001. Epub 2018 Jul 17.

Association between Development of Dementia and Use of Benzodiazepines: A Systematic Review and Meta-Analysis

Lucchetta RC, da Mata BPM, Mastroianni PC.

Pharmacotherapy. 2018 Oct;38(10):1010-1020. doi: 10.1002/phar.2170. Epub 2018 Sep 6.

[Arterial hypertension, cognitive disorders and dementia: a view of a cardiologist]

Ostroumova OD, Cherniaeva MS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(9):117-125. doi: 10.17116/jnevro2018118091117.

Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease

Lombardi G, Polito C, Berti V, Bagnoli S, Nacmias B, Pupi A, Sorbi S.

J Alzheimers Dis. 2018;66(4):1389-1395. doi: 10.3233/JAD-180736.

Statins: The Burglar of Memory?

Downs TN.

Consult Pharm. 2018 Dec 1;33(12):706-710. doi: 10.4140/TCP.n.2018.706..

Natural Polyphenols in the Treatment of Alzheimer's Disease

Syarifah-Noratiqah SB, Naina-Mohamed I, Zulfarina MS, Qodriyah HMS.

Curr Drug Targets. 2018;19(8):927-937. doi: 10.2174/1389450118666170328122527.

Hydroxypyridinone Derivatives: A Fascinating Class of Chelators with Therapeutic Applications - An Update

Chaves S, Piemontese L, Hiremathad A, Santos MA.

Curr Med Chem. 2018;25(1):97-112. doi: 10.2174/0929867324666170330092304.

Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research

Jankowska A, Wesolowska A, Pawlowski M, Chlon-Rzepa G.

Curr Med Chem. 2018;25(17):2045-2067. doi: 10.2174/0929867324666170529122802.

The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview

Jakki SL, Senthil V, Yasam VR, Chandrasekar MJN, Vijayaraghavan C.

Curr Drug Targets. 2018;19(2):155-169. doi: 10.2174/1389450118666170612100750.

Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis

Mueller C, Perera G, Hayes RD, Shetty H, Stewart R.

Age Ageing. 2018 Jan 1;47(1):88-94. doi: 10.1093/ageing/afx098.

Effects and mechanisms of actions of phytochemicals on Alzheimer's disease neuropathology

Hartman RE, Ross DM.

Front Biosci (Elite Ed). 2018 Jan 1;10(2):300-333. doi: 10.2741/e824.

CORAL: Monte Carlo Method to Predict Endpoints for Medical Chemistry

Toropova AP, Toropov AA.

Mini Rev Med Chem. 2018 Feb 14;18(5):382-391. doi: 10.2174/1389557517666170927154931.

Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment

De Matteis L, Martín-Rapún R, de la Fuente JM.

Curr Med Chem. 2018;25(35):4602-4615. doi: 10.2174/0929867324666171012112026.

Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease

Li H, Wang X, Yu H, Zhu J, Jin H, Wang A, Yang Z.

Curr Neuropharmacol. 2018;16(6):758-768. doi: 10.2174/1570159X15666171030142108.

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Schelter BO, Wischik DJ, Davis CS, Staff RT, Vuksanovic V, Ahearn T, Bracoud L, Shamsi K, Marek K, Seibyl J, Riedel G, Storey JMD, Harrington CR, Wischik CM.

J Alzheimers Dis. 2018;61(1):435-457. doi: 10.3233/JAD-170560.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias